Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2051–2100 of 18616
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
Immediately after the consummation of the Merger, Anthony L. Hemmelgarn and Timo Nentwich have been appointed as the Chief Executive Officer and Chief Financial Officer, respectively, of the Surviving Corporation.
Immediately after the consummation of the Merger, Anthony L. Hemmelgarn and Timo Nentwich have been appointed as the Chief Executive Officer and Chief Financial Officer, respectively, of the Surviving Corporation.
John Power, the former President and CEO of the Company resigned as President and CEO
Koby Kushner was appointed to serve as President and CEO of the Company
On March 21, 2025, Jessica Buss notified Argo Group International Holdings, Inc. (the “Company”) of her resignation as Chief Executive Officer of the Company, effective immediately
Christopher Donahue, the Company’s Chief Financial Officer, was appointed as the Chief Executive Officer of the Company
David Chan, the Company’s Chief Accounting Officer, was appointed as the Chief Financial Officer of the Company
On March 27, 2025, by mutual agreement, Mr. Fricker will no longer serve as interim Chief Financial Officer.
Maria Maccecchini will continue to serve as principal financial officer on an interim basis.
On March 27, 2025, the Board of Directors (the “Board”) of Wolfspeed, Inc. (the “Company”) appointed Robert Feurle to serve as the Company’s Chief Executive Officer and a member of the Board, effective May 1, 2025
Effective March 27, 2025, Vineet Agarwal, Chief Financial Officer of Korro Bio, Inc., or the Company, ended his temporary medical leave of absence, which had been in effect since February 11, 2025.
Dr. Ram Aiyar, who had been serving as the Company’s interim principal financial officer, is no longer serving in that role as of March 27, 2025 and continues to serve as the Company’s President and Chief Executive Officer (principal executive officer).
The employment of Thomas Butler as Chief Executive Officer of the Company ended on March 25, 2025 (the “Effective Date”).
Dr. Hitchcock, a member of the Board, was appointed as the Company’s interim Chief Executive Officer and principal executive officer
Rainer (Ramses) Erdtmann, the Company’s President, Chief Operating Officer and a member of the Board, was appointed as the Company’s principal financial officer and principal accounting officer
On March 24, 2025, Pacific Biosciences of California, Inc. (the “Company”) entered into an offer letter with Jim R. Gibson to serve as its Chief Financial Officer. Mr. Gibson will be appointed as the Company’s Chief Financial Officer and principal financial officer effective as of as his first date of employment, which is anticipated to be March 31, 2025
Christian Henry, the Company’s President and Chief Executive Officer, who has been serving also as the Company’s interim Chief Financial Officer and principal financial officer since December 6, 2024 will cease serving as interim Chief Financial Officer and principal financial officer upon commencement of Mr. Gibson’s employment but will continue serving as the Company’s President and Chief Executive officer.
John Witek, who served as Interim Chief Financial Officer and Chief Accounting Officer, is retiring effective March 31, 2025.
The Board has named Jost Fischer, the current Chairman of the Board, to serve as Interim CEO following Mr. Forth’s departure while the Board identifies a replacement CEO.
On March 24, 2025, AEON Biopharma, Inc. (the “Company” or “AEON”) was notified by Marc Forth that he intended to resign as the Company’s President and Chief Executive Officer (“CEO”) in order to pursue another opportunity.
Effective as of Levin Transition Date, the Board appointed Nadir Mahmood, Ph.D., the Company’s President, to succeed Ms. Levin as the Company’s principal financial officer and principal accounting officer.
On March 26, 2025, the Company announced that Alyssa Levin’s employment would be terminated effective March 31, 2025
On the Effective Date, Richard F. Westenberger, currently serving as the Company’s Interim Chief Executive Officer, will no longer serve in that capacity but will continue with the Company as its Senior Executive Vice President, Chief Financial Officer & Chief Operating Officer.
the Board of Directors of the Company (the “ Board ”) approved the appointment of Douglas C. Palladini as Chief Executive Officer and President of the Company and a member of the Board, effective April 3, 2025
On March 24, 2025, David Finn submitted his resignation as Executive Vice President and Chief Financial Officer of the Company and the Bank, the Company’s wholly-owned subsidiary, effective as of May 15, 2025 or as otherwise determined by Mr. Finn and the Company, to ensure a seamless transition.
On March 12, 2025, the Board of Directors of the Company (“Board”) appointed Jeremy White, age 45, to serve as the Company’s Chief Executive Officer effective March 17, 2025.
On March 21, 2025, Joseph G. Dwyer notified Golden Minerals Company (the “Company”) that he would be resigning as Chief Financial Officer of the Company, effective on May 31, 2025, to pursue other opportunities.
the employment of each of Adrienne “Deanie” Elsner, Chief Executive Officer, Susan Keefe, Chief Financial Officer, and Jason Bull, Chief Technology Officer, was terminated without cause.
Effective March 19, 2025, immediately following the March 19 Board Meeting, the Company appointed Daniel Cosgrove, previously Chief Administrative Officer and General Counsel, to serve as the Company’s interim Chief Executive Officer, General Counsel and Secretary of the Company.
the employment of each of Adrienne “Deanie” Elsner, Chief Executive Officer, Susan Keefe, Chief Financial Officer, and Jason Bull, Chief Technology Officer, was terminated without cause.
Robyn Bradbury, age 42, the current Senior Vice President of Finance and Investor Relations, will become the Chief Financial Officer of the Company
Mark R. Witkowski, age 50, the current Chief Financial Officer, will become the Chief Executive Officer of the Company
On March 24, 2025, KB Home announced the appointment, effective March 31, 2025, of Robert R. Dillard as its Executive Vice President and Chief Financial Officer.
at which time Sunit Patel will assume the role of EVP and CFO as previously announced on March 12, 2025.
Steven J. Moskowitz ceased to serve as the Company’s President and Chief Executive Officer (“CEO”), effective March 23, 2025.
the Company’s board of directors (“Board”) appointed Daniel K. Schlanger, the Company’s Executive Vice President (“EVP”) and Chief Financial Officer (“CFO”), to serve as Interim President and CEO of the Company (“Interim CEO”), effective March 23, 2025
On March 18, 2025, the Board of Directors (the “Board”) of Spire Global, Inc. (the “Company”) approved, effective on April 1, 2025, (i) the removal of Mr. Krywe as interim Chief Financial Officer, principal financial officer and principal accounting officer of the Company and (ii) the appointment of Alison Engel as Chief Financial Officer, principal financial officer and principal accounting officer of the Company.
On March 18, 2025, the Board of Directors (the “Board”) of Spire Global, Inc. (the “Company”) approved, effective on April 1, 2025, (i) the removal of Mr. Krywe as interim Chief Financial Officer, principal financial officer and principal accounting officer of the Company and (ii) the appointment of Alison Engel as Chief Financial Officer, principal financial officer and principal accounting officer of the Company.
the Board of Directors (the “Board”) has appointed David M. Gray as Chief Financial Officer of the Company, effective as of March 24, 2025.
On March 18, 2025, the Board of Directors of Neonode Inc. (the “Company”) approved the appointment of Daniel Alexus as President and Chief Executive Officer and as Managing Director of the Company, effective March 31, 2025.
On March 17, 2025, the board of directors (the “Board”) appointed Ms. Xian Nan (Delia) Zheng (“Ms. Zheng”) as the new Chief Financial Officer.
On March 17, 2025, Mr. Xue Zhi Ma resigned as CFO of Summit Networks Inc. (the “Company”).
On March 21, 2025, the Board appointed Monica Kelsey as Chief Financial Officer of the Company effective as of the close of business on March 21, 2025.
On March 20, 2025, Venugopal Rathi notified the Board of Trustees (the “Board”) of the Company of his resignation as the Company’s Chief Financial Officer.
the Board appointed Monica Kelsey as Chief Financial Officer of the Company effective as of the close of business on March 21, 2025.
Venugopal Rathi notified the Board of Trustees (the “Board”) of Antares Strategic Credit Fund (the “Company”) of his resignation as the Company’s Chief Financial Officer.
appointed Carl Russell (“Buck”) Fletcher IV, an employee of FIG LLC, our external manager (our “Manager”), as the Company’s Chief Financial Officer and Chief Accounting Officer, effective immediately.
Mr. Fletcher succeeds Scott Christopher, the Company’s current Chief Financial Officer and Chief Accounting Officer, who will cease serving in such roles effective immediately.
Mr. Mathewes will return from the leave of absence and resume his duties and responsibilities effective March 24, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.